CTi Biopharma Corp Top Management
CTi Biopharma employs about 127 people. The company is managed by 7 executives with a total tenure of roughly 8 years, averaging almost 1.0 years of service per executive, having 18.14 employees per reported executive. Evaluation of CTi Biopharma's management performance can provide insight into the firm performance.
| David Kirske President CFO, Executive Vice President |
CTi |
CTi Biopharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.2858) % which means that it has lost $0.2858 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.1875) %, meaning that it created substantial loss on money invested by shareholders. CTi Biopharma's management efficiency ratios could be used to measure how well CTi Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.CTi Biopharma Workforce Comparison
CTi Biopharma Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,483. CTi Biopharma holds roughly 127 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.91) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.74) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.74. CTi Biopharma Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CTi Biopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on CTi Biopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CTi Biopharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Reed Tuckson over a year ago Acquisition by Reed Tuckson of 80000 shares of CTi Biopharma subject to Rule 16b-3 | ||
Reed Tuckson over a year ago Bona fide gift to Reed Tuckson of 43785 shares of CTi Biopharma subject to Section 16 |
CTi Biopharma Notable Stakeholders
A CTi Biopharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CTi Biopharma often face trade-offs trying to please all of them. CTi Biopharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CTi Biopharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David Kirske | CFO, Executive Vice President | Profile | |
| Ed Bell | Director - Investor Relations | Profile | |
| Jennifer Smith | VP Biometrics | Profile | |
| James Fong | Ex Officer | Profile | |
| Bruce Bennett | VP Operations | Profile | |
| John Volpone | Ex Staff | Profile | |
| MBA MD | CEO and President | Profile |
CTi Biopharma Workforce Analysis
Traditionally, organizations such as CTi Biopharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CTi Biopharma within its industry.CTi Biopharma Manpower Efficiency
Return on CTi Biopharma Manpower
| Revenue Per Employee | 424.8K | |
| Revenue Per Executive | 7.7M | |
| Net Loss Per Employee | 732.2K | |
| Net Loss Per Executive | 13.3M | |
| Working Capital Per Employee | 143.8K | |
| Working Capital Per Executive | 2.6M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in CTi Stock
If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |